XML 9 R2.htm IDEA: XBRL DOCUMENT v3.25.4
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2025
Mar. 31, 2025
Assets    
Cash and cash equivalents $ 4,721 $ 5,972
Accounts receivable, net 13,249 12,845
Revenue earned but not billed 3,611 3,350
Inventories, net 9,866 11,392
Prepaid expenses and other current assets 1,356 1,939
Total current assets 32,803 35,498
Property and equipment, net 7,367 8,026
Goodwill 1,484 1,484
Other intangible assets, net 2,770 3,379
Other long-term assets 3,827 4,076
Total assets 48,251 52,463
Liabilities and Shareholders’ Equity    
Accounts payable 14,522 13,272
Accrued expenses and other 8,717 12,728
Deferred revenue, current 190 491
Current maturities of long-term debt 803 353
Total current liabilities 24,232 26,844
Revolving credit facility 5,750 7,000
Long-term debt, less current maturities 3,291 2,971
Deferred revenue, long-term 281 337
Other long-term liabilities 2,858 3,427
Total liabilities 36,412 40,579
Commitments and contingencies
Shareholders’ equity:    
Preferred stock, $0.01 par value: Shares authorized: 30,000,000 at December 31, 2025 and March 31, 2025; no shares issued and outstanding at December 31, 2025 and March 31, 2025 0 0
Common stock, no par value: Shares authorized: 20,000,000 at December 31, 2025 and March 31, 2025; shares issued: 4,314,582 at December 31, 2025 and 4,247,023 at March 31, 2025; shares outstanding: 3,552,077 at December 31, 2025 and 3,298,389 at March 31, 2025 0 0
Additional paid-in capital 163,345 163,025
Treasury stock, common shares: 762,509 at December 31, 2025 and 948,634 at March 31, 2025 (34,948) (36,248)
Accumulated deficit (116,558) (114,893)
Total shareholders’ equity 11,839 11,884
Total liabilities and shareholders’ equity $ 48,251 $ 52,463